Dr. Kimberly Yonkers discusses conditions that increase a patient's risk for suicide as well as what steps clinicians can take to improve care for at-risk patients.
Kimberly Yonkers, MD, professor of psychology, of epidemiology and of obstetrics, gynecology and reproductive sciences; Director, Division of Psychological Medicine; Director, Center for Wellbeing of Women and Mothers, Yale School of Medicine, New Haven, Conn.
I talked a little bit about how clinicians can talk to patients and ask them about depressive symptoms as well as thoughts about self-harm or thoughts about suicide, and I also presented a model which tries to sort of incorporate some of the risk factors that we know are related to suicide, such as genetics, as well as psychiatric illness, and having the means by which somebody could complete a suicide attempt.
Well, I think the first and most important thing is to transmit to patients that you are concerned about their health and that you want to help them. And then, if somebody discloses that they have difficulty with something like depression or a severe anxiety disorder – so, for example, PTSD, which is Post Traumatic Stress Disorder – are they in treatment, are they benefitting from treatment? And if they’re symptomatic, whether they’re in treatment or not, that relationship can go a long way to really understanding if somebody is at risk for thoughts of self-harm, and it can also go a long way in terms of referring them to a mental health provider who can then take the next step and help patients care for themselves.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More